Phase 1 Liver Cancer Trial, Recruiting (NCT04842812)

Phase 1 Liver Cancer Trial, Recruiting NCT04842812 Sponsor: Second Affiliated Hospital of Guangzhou Medical University Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04842812 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have advanced cancer that has not responded to currently available treatments
Doctors expect you to live for more than 12 weeks
Your heart, lungs, liver, and kidneys are all working well enough (confirm with trial site)
A tissue sample (biopsy) or fluid sample from your cancer can be collected for the study
You (or your legal guardian) are willing and able to read, understand, and sign a consent form

Who may not be able to join:

You have had gene therapy in the past
You have a serious viral infection, such as Hepatitis B, Hepatitis C, or HIV, or you have tested positive for HIV
You currently have an active infection caused by bacteria, a virus, or fungi
You have another serious illness that the trial doctors feel would make participation unsafe (confirm with trial site)
You are currently pregnant or breastfeeding
You are taking steroids at a medium-to-high daily dose (such as prednisone or a similar medication) — confirm the exact dose threshold with the trial site
There are other health or personal reasons the trial doctors feel would make participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University

Phone: +862039195966

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04842812

Sponsor: Second Affiliated Hospital of Guangzhou Medical University

Phase: Phase 1

Status: Recruiting

Condition: Liver Cancer

Trial contact: +862039195966

More information: https://clinicaltrials.gov/study/NCT04842812

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have advanced cancer that has not responded to currently available treatments
Doctors expect you to live for more than 12 weeks
Your heart, lungs, liver, and kidneys are all working well enough (confirm with trial site)
A tissue sample (biopsy) or fluid sample from your cancer can be collected for the study
You (or your legal guardian) are willing and able to read, understand, and sign a consent form

Who may not be able to join:

You have had gene therapy in the past
You have a serious viral infection, such as Hepatitis B, Hepatitis C, or HIV, or you have tested positive for HIV
You currently have an active infection caused by bacteria, a virus, or fungi
You have another serious illness that the trial doctors feel would make participation unsafe (confirm with trial site)
You are currently pregnant or breastfeeding
You are taking steroids at a medium-to-high daily dose (such as prednisone or a similar medication) — confirm the exact dose threshold with the trial site
There are other health or personal reasons the trial doctors feel would make participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Registry

ClinicalTrials.gov

Start date

1 January 2021

Est. completion

31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Safety of TILs/CAR-TILs treatment in advanced solid cancers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov